Learn how to prevent bindness by actively monitoring your vision and knowing how to spot the warning signs.
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will showcase key real-world, product and pipeline data from its ophthalmology portfolio at the Association ...
Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing ...
Global Vitreoretinal Surgery Devices Market growth is Driven by Increasing Prevalence of Vision-Threatening Retinal Diseases, Expanding Geriatric Population.Austin, United States, May 11, 2026 (GLOBE ...
Startups have developed chips that allow people to control machines with their thoughts. Billionaires are betting these brain ...
Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, announced the completion of the adult dose escalation portion of the STELLAR phase 1/2 clinical trial ...
Science fiction has long imagined a world where our brains interact with machines to restore and augment our abilities—think ...
The Labour government is trying to reduce road deaths through its Road Safety Strategy, with cognitive and eyesight testing ...
Researchers have been working for decades on so-called brain-computer interfaces to help people who suffer from paralysis, ...
Six potential changes are being considered for drivers aged 70 and over as part of a Labour Party government consultation.
Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results